FDA: AstraZeneca’s Crestor Slows Hardening of Arteries

AstraZeneca Plc. said that it has received Food and Drug Administration approval to advertise that its Crestor cholesterol reducer also slows the progression of atherosclerosis, or hardening of the arteries.
The News Journal